Table of Contents
What changed
Statutory revenue rose 60.0% to NZ$18.8m from NZ$11.7m, but losses widened at every line. PBT deteriorated 22.6% to a loss of NZ$19.6m, and NPAT fell 20.2% to a NZ$19.7m loss. Operating cash outflow increased to NZ$17.0m from NZ$14.4m. The most consequential balance-sheet movement was cash, which fell NZ$118.7m to NZ$17.9m (-86.9%) versus the HY22 snapshot of NZ$136.5m. Total equity contracted 9.4% to NZ$133.8m while total liabilities rose 80.3% to NZ$19.2m. Capex was cut to NZ$0.2m from NZ$2.4m, taking capex intensity to 1.2% of revenue from 20.7%. The release also highlights non-statutory "segment revenue" of NZ$20.3m (+106%) and an EBITDAF figure of NZ$16.9m with no reconciliation to the statutory loss.
What matters
- Scale is arriving, but unit economics have not yet tipped. Revenue growth of 60% did not close the gap on operating losses; operating loss widened from NZ$16.4m to NZ$22.9m. The revenue base is still too small to absorb the cost structure.
- Liquidity is the dominant read. Closing cash of NZ$17.9m against a first-half operating outflow of NZ$17.0m and a pre-lease FCF outflow of NZ$17.2m leaves very thin headroom relative to the prior-year NZ$136.5m position. The group remains debt-free, but the cushion that supported a "fund from cash" posture has largely been consumed.
- The cashflow-positive-by-FY25 target now carries more weight. With no numeric milestone disclosed, the qualitative target has to be read against a current half that still burned cash at roughly prior-period levels despite revenue nearly doubling at the reported "segment" level.
Expectations
FY23 revenue guidance was affirmed, but no quantum was extracted, so this release cannot be benchmarked against a specific number. Shape context is mixed: in FY22, the first half captured 56.6% of full-year revenue and only 35.9% of full-year NPAT loss, meaning the second half was larger on losses than on revenue. Annualising HY23 revenue gives roughly NZ$37.6m, well above FY22's NZ$20.7m, but the FY22 first-half weighting means a simple double likely overstates a normalised full-year figure. The stated FY25 cashflow-positive target is qualitative only; no CAGR bridge is calculable from the disclosures provided.
Quality of result
The revenue growth looks real: booking volumes are up 73% and ARPU up 54% per the release, and receivable days compressed from 60.1 to 32.5, suggesting collections, not stretched terms, are supporting the top line. What is not durable-looking is the cash profile. Pre-lease free cash flow was NZ$-17.2m versus NZ$-16.9m a year earlier, essentially unchanged, even though capex fell by NZ$2.2m. In other words, the capex cut masked a worsening operating cash position — operating outflow deteriorated by NZ$2.5m. Cash conversion therefore deteriorated materially. Tax does not distort the picture: effective tax was 0.7% in HY23 and 2.8% in HY22, so PBT and NPAT growth track closely (-22.6% vs -20.2%). The EBITDAF figure quoted in the release is not reconciled to the statutory loss in the extracted material and should not be taken as a substitute earnings read.
Unresolved
- How much runway does NZ$17.9m of cash actually provide given current burn, and is any facility, capital raise, or working-capital lever assumed in the path to FY25 cashflow positive?
- What reconciles the release's "EBITDAF NZ$16.9m, up 44%" and "segment revenue NZ$20.3m" to statutory revenue of NZ$18.8m and an operating loss of NZ$22.9m? No reconciliation was provided.
- Why did total liabilities rise 80.3% to NZ$19.2m when gross borrowings are zero, and what is the composition of that increase?
- Is the 27.6-day fall in receivable days a step-change in collections or a mix effect from faster-settling transactional revenue, and is it sustainable?
This briefing cannot assess valuation, customer or geographic concentration, or the credibility of the FY25 cashflow-positive target, because none of the required disclosures were present in the extracted data.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $18.8m | $11.7m | +60.0% ↑ |
| Net profit after tax | −$19.7m | −$16.4m | -20.2% ↓ |
| Net cash inflow from operating activities | −$17.0m | −$14.4m | -17.4% ↓ |
| Operating profit | −$22.9m | −$16.4m | -39.8% ↓ |
| Profit before tax | −$19.6m | −$16.0m | -22.6% ↓ |
| Cash and cash equivalents | $17.9m | $136.5m | -86.9% ↓ |
| Total assets | $153.0m | $158.3m | -3.3% ↓ |
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| FCF pre-lease | −$17.2m | −$16.9m | −$0.3m |
| FCF / NPAT | 87.1% | 102.8% | complementary conversion metric |
| Capex % revenue | 1.2% | 20.7% | — |
| Capex | −$0.2m | −$2.4m | +$2.2m |
| Debtor days | 32.5 | 60.1 | -27.6 days |
| Trade debtors | $3.4m | $3.9m | −$0.5m |
| Net debt | −$17.9m | −$136.5m | +$118.7m |
| Gross borrowings | $0.0m | — | — |
| HY22 share of FY22 revenue | 56.6% | — | Other half was 43.4% |
| HY22 share of FY22 NPAT | 35.9% | — | Other half was 64.1% |
| Profit from continuing operations | −$19.7m | — | — |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.